Hemispherx Biopharma (HEB)

0.37 +0.04  +10.45%  Feb 10, 11:00PM Go Pro
Watch
View Full Chart HEB Price Chart

Key Stats

Market Cap 50.13M
Revenue Growth 28.57%
Profit Margin -6088.89%
Earnings Yield -18.92%
Dividend Yield 0.00%
Earnings Per Share TTM -0.07
PE Ratio
Price / Sales Ratio 334.18
52 Week High 0.57
52 Week Low 0.17
Beta 0.97
View Pro Ratings Details

YCharts Pro Ratings

Go Pro.
Learn More
  • Pro Value Score Go Pro
  • Pro Fundamental Score Go Pro
  • Pro Valuation from Historical Multiples Go Pro

News

Feb 03 $HEB , I am early but bot it this morning. loking for a nice pop by 3DTRADINGTRADER
Feb 01 Looks like $heb bottomed at .36 by russ11
Jan 30 Gilead Sciences Inc. Fourth Quarter Earnings Sneak Peek
Jan 30 from $prot to $heb...weeeee by sniper
Jan 30 @ACInvestorBlog thanks for this idea. $heb by russ11
Jan 27 @EXPstocktrader any opinion on $heb ? just got small pos. by russ11
Jan 27 $HEB hod pop by tradueruski
Jan 27 $HEB booom hod by tradueruski
Jan 27 $heb going going gone.. by sniper
Jan 26 Benzinga's Microcap Movers for Thursday January 26, 2012 Benzinga
Jan 26 Hemispherx Biopharma genital warts drug OK’d in Argentina
Jan 26 Hemispherx Biopharma Gains Regulatory Approval in Latin America Benzinga
Jan 23 Swine Flu Outbreak in Mexico Sends Small BioPharma Sky-High Benzinga

Profile

Exchange: AMEX       Sector: Healthcare       Industry: Biotechnology

1 Year Total Return Performance

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Hemispherx Biopharma is down N/A over the last year vs S&P 500 Total Return up N/A, BioCryst Pharmaceuticals down N/A, and Novavax down N/A.

  • HEB Total Returns
  • ^SPXTR Total Returns
  • BCRX Total Returns
  • NVAX Total Returns

Fundamentals

Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.

Income Statement View Statement

Get Quote for

Pro Strategies Featuring HEB

Did Hemispherx Biopharma make it into our Pro Portfolio Strategies?

Start your YCharts Pro membership now to find out.

HEB Charts

Recent Quotes

Symbol Price Chg Chg % Market Cap
HEB 0.37 0.04 10.45% 50.13M
ACAS 8.69 0.15 1.76% 3.00B
BEST 0.62 -0.11 -15.07% 17.07M
ATPG 6.69 -0.14 -2.05% 345.34M
JRCC 6.38 -0.51 -7.40% 227.13M
FMCN 23.47 -0.76 -3.14% 3.40B
CYTK 1.18 -0.01 -0.84% 85.29M
VECO 28.36 0.08 0.28% 1.10B
SHLD 47.57 -0.82 -1.69% 5.09B
CBI 43.42 -0.23 -0.53% 4.28B
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close